Genomictree Decides to Acquire 4.62% Stake in Optorain Worth 5 Billion KRW

[Asia Economy Reporter Minwoo Lee] Genomictree announced on the 27th that it has decided to acquire 4.67% (49,367 shares) of Optorain, a manufacturer of semiconductor-based digital PCR and in vitro diagnostic devices, for approximately 5 billion KRW in cash. The company explained that this is a "strategic collaboration for the effective development of innovative body fluid-based early cancer diagnosis and simultaneous multi-marker diagnosis technology."

This content was produced with the assistance of AI translation services.